30 October 2024
Malaysia
Government Shouldn’t Restrain IJN’s Ability To Decide What’s Best For Patients: Galen Centre
With Putrajaya directing IJN to switch public patients to generic drugs, the Galen Centre acknowledges MOH's funding constraints, but says IJN shouldn't have "one hand tied behind its back in deciding what is best for patients entrusted under their care."